 |
市场调查报告书
商品编码
1198730
椎骨压缩性骨折器械市场-增长、趋势、COVID-19 影响和预测 (2023-2028)Vertebral Compression Fracture Devices Market - Growth, Trends, and Forecasts (2023 - 2028) |
||||||
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
在预测期内 (2022-2027)，椎骨压缩性骨折器械市场预计将以 8.3% 的复合年增长率增长。
COVID-19 对脊椎压缩性骨折装置的流行产生了重大影响，因为重点是抗击 COVID-19 感染和减少脊柱手术。 例如，根据《世界神经外科杂誌》上发表的题为“COVID-19 大流行对中欧脊柱手术的影响”的研究，“COVID-19 感染对中欧脊柱手术的影响。一项基于问卷调查的研究” 2021 年 9 月，在中欧，COVID-19 大流行限制了脊柱外科病房的监管。 择期手术减少，可以将更多资源分配给严重急性呼吸道冠状病毒感染患者。
推动这一市场发展的主要因素包括骨质疏鬆症和关节炎负担的增加、外伤和癌症负担的增加、脊柱手术的进步以及微创手术意识的提高。
根据发表在《骨科外科与研究杂誌》上的一项题为“全球骨质疏鬆症患病率：2021 年 10 月的全面系统回顾和荟萃分析”的研究，骨质疏鬆症的全球患病率为 18.3%。 女性骨质疏鬆症的全球患病率为 23.1%，而男性骨质疏鬆症的全球患病率为 11.7%。 他们还发现，18 岁至 95 岁的人群患骨质疏鬆症的频率最高。 骨关节炎患者日常简单运动就容易发生椎体压缩性骨折，骨关节炎的负担在世界范围内都很高，期待有用。
此外，由于这些设备的采用率不断提高，预计主要市场参与者通过推出自己的产品而采取的更多举措将进一步推动研究市场的增长。 例如，2020 年 9 月，ZI Medical Products, LLC 的 Kiva 椎体压缩性骨折（VCF）治疗系统在欧洲获得 CE 标誌认证。 这是一种使用单隔室 PEEK 植入物的 VCF 治疗方法，已在美国取得临床和商业上的成功。
此外，2020 年 8 月，IZI Medical Products 推出了 Osteosite Vertebral Balloon，这是一种用于椎体增强手术的球囊。 Osteosite Balloon 完善了 IZI 提供的椎体压缩性骨折 (VCF) 治疗方案，包括骨细胞椎体成形术和骨细胞球囊延长术、Blazer 曲线针延长术和 Kiva PEEK 植入物延长术。骨细胞球囊是 IZI 提供的椎体压缩性骨折的最佳治疗选择。 这些在市场上推出新产品的努力将进一步推动市场的增长。
除上述因素外，对于 55 岁以下没有或仅有轻微创伤的个体，应评估转移性癌症作为椎骨压缩性骨折原因的可能性。 已知许多恶性肿瘤会通过脊柱骨转移。 然后，癌症可能会破坏部分椎骨，削弱它们直至塌陷。 例如，2020年12月，国际癌症研究机构（IARC）发布的最新报告《Globocan 2020》指出，2020年全球将有1930万癌症患者和1000万癌症死亡人数。到
但是，与术后并发症（例如出血、椎骨后部骨折）、设备的严格监管批准以及报销问题相关的风险预计会阻碍市场增长。
椎体压缩骨折器械市场趋势
预计在预测期内，微创脊柱外科领域将占很大份额
微创脊柱手术领域预计将占据重要的市场份额，并且很可能在预测期内占据这一份额。
灌注技术的创新、脊柱融合术的改进以及专业手术器械和机器人技术的发展提供了将椎体压缩性骨折手术推进到微创方法所需的工具。 微创脊柱 (MIS) 手术的目标是稳定椎骨和脊柱关节并减轻脊神经的压力。 它通常由椎体压缩性骨折、椎体不稳定、骨刺、椎间盘突出、脊柱侧凸和脊柱肿瘤等情况引起。
预计椎体压缩骨折器械市场中市场参与者的积极性将进一步推动该细分市场的增长。 例如，2021 年 2 月，DePuy Synthes 与 Expanding Innovations 签署了一项协议，在美国销售 X-Pac 可扩展腰椎笼式系统。 X-Pac Cage 是 DePuy Synthes 现有产品线的补充，可在退行性腰椎和微创脊柱节段中实现更彻底的手术。
此外，2021 年 10 月，美敦力 (Medtronic) 将在其微创脊柱技术生态系统中引入三款新设备，这是一家为外科医生和患者融合脊柱植入物、生物製剂、导航、机器人技术和人工智能数据的公司。 因此，预计脊柱手术设备主要参与者的此类举措将在预测期内推动该细分市场的增长。
因此，由于上述因素，预计该细分市场将在预测期内获得牵引力。
北美占据主要市场份额，预计在预测期内保持不变
北美在椎体压缩骨折装置市场中占据主要份额，预计在预测期内也将如此。
该地区的市场增长因素包括微创手术的进步、目标疾病患病率的上升、创伤相关头部和脊柱损伤研究经费的增加，以及主要市场参与者的稳固立足点。
根据美国疾病控制与预防中心发布的《骨关节炎国家公共卫生议程：2020年更新》报告，骨关节炎（OA）是最常见的关节炎形式，是一种严重的慢性疾病，影响7人中有1人，影响3250万人。 骨质疏鬆症等高发病率预计将推动该地区研究市场的增长，因为椎体压缩骨折装置被广泛用于治疗与骨质疏鬆症相关的骨折。
此外，主要市场参与者的主动性不断提高预计也将在预测期内推动该地区的市场增长。 例如，2021 年 8 月，Vertefix HV Cement 是一种独特的解决方案，可满足椎体成形术和枕骨成形术中水泥注射过程中实时流动可视化的需求，可用于治疗椎体压缩性骨折。它由 IZI Medical Products LLC 销售，治疗介入放射学设备和产品的製造商。 这些努力有望促进水泥的采用和椎体压缩性骨折治疗装置的引入，促进美国市场的增长。
此外，根据《2021 年美国健康排名高级报告》，美国 65 岁及以上的人口超过 5400 万。 美国老年人口数量急剧膨胀，到2050年，美国65岁及以上人口总数预计将达到8570万，占总人口的近20%。 由于椎骨压缩性骨折在老年人中更常见，预计老年人口的增加将推动该地区的市场增长。
在此背景下，预计该地区的市场在预测期内将会增长。
椎体压缩骨折器械市场竞争者分析
椎体压缩骨折器械市场竞争激烈。 市场预计将受到主要市场参与者增加产品发布以及市场参与者之间合作伙伴关係、併购的增加的推动。 市场上的主要参与者包括 Spirit Spine Holding Corporation Inc、IZI Medical Products、Stryker Corporation (Orthovita, Inc.)、Orthofix Interventional N.V.、Johnson and Johnson (DePuy Synthes)、Globus Medical, Inc 和 Merit Medical Systems Inc。它包括公司如
其他好处
- Excel 格式的市场预测 (ME) 表
- 三个月的分析师支持
内容
第1章介绍
- 研究假设和市场定义
- 调查范围
第2章研究方法论
第 3 章执行摘要
第4章市场动态
- 市场概览
- 市场驱动力
- 增加关节炎和骨质疏鬆症的负担
- 由于外伤、癌症或其他原因导致脊柱受压而增加负担
- 提高对脊柱手术进展的认识
- 市场製约因素
- 与出血和椎骨后部骨折等术后并发症相关的风险
- 严格的监管审批程序和报销问题
- 波特的五力分析
- 新进入者的威胁
- 买方/消费者议价能力
- 供应商的议价能力
- 替代品的威胁
- 竞争公司之间的敌对关係
第 5 章市场细分（市场规模：百万美元）
- 按产品类型
- Balloon Cubo Platy
- 椎板成形术
- 通过手术
- 开放式脊柱手术
- 微创脊柱手术
- 最终用户
- 医院
- 门诊手术中心
- 其他（外伤中心、其他）
- 按地区
- 北美
- 美国
- 加拿大
- 墨西哥
- 欧洲
- 德国
- 英国
- 法国
- 意大利
- 西班牙
- 其他欧洲地区
- 亚太地区
- 中国
- 日本
- 印度
- 澳大利亚
- 韩国
- 其他亚太地区
- 中东
- 海湾合作委员会
- 南非
- 其他中东地区
- 南美洲
- 巴西
- 阿根廷
- 其他南美洲
- 北美
第6章竞争格局
- 公司简介
- Spirit Spine Holding Corporation Inc
- Medtronic Inc.
- IZI Medical Products
- Stryker Corporation（Orthovita, Inc.）
- Spine Wave, Inc.
- Orthofix Interventional N.V.
- Zimmer Biomet
- Johnson and Johnson（DePuy Synthes）
- Zavation
- Globus Medical, Inc.
- Merit Medical Systems Inc.
第7章 市场机会与今后动向
The Vertebral Compression Fracture Devices Market is expected to register a CAGR of 8.3 % during the forecast period (2022-2027).
COVID-19 has significantly impacted the vertebral compression fracture devices during the pandemic due to the shift of focus towards the battling of COVID-19 infection and the decrease in spine surgeries. For instance, according to the study published in World Neurosurgery, titled 'The Impact of the COVID-19 Pandemic on Spine Surgery in Central Europe: A Questionnaire-Based Study' in September 2021, in Central Europe, the COVID-19 pandemic resulted in limiting regulations for spinal surgery units. Elective surgical operations were decreased, allowing more resources to be allocated to patients with severe acute respiratory coronavirus infections.
The major factors driving this market include the growing burden of osteoporosis and arthritis, the rising burden of trauma and cancers, increase in awareness about the advancements in spinal surgeries and minimally invasive surgeries, among others.
According to the study published in the Journal of Orthopaedic Surgery and Research, titled 'The global prevalence of osteoporosis in the world: a comprehensive systematic review and meta-analysis in October 2021, the global prevalence of osteoporosis was estimated to be 18.3 %. The global prevalence of osteoporosis in women was found to be 23.1 percent, whereas the global prevalence of osteoporosis in males was found to be 11.7 percent. People between the ages of 18 and 95 were found to have the highest frequency of osteoporosis. As osteoarthritic patients are prone to vertebral compression fractures by simple daily activities, the market is expected to drive due to the huge burden of osteoarthritis globally due to the rise in the adoption of vertebral compression fracture devices.
In addition, a rising initiative from the key market players by the launch of their products is further expected to drive the growth of the market studied due to the rise in the adoption of these devices. For instance, in September 2020, The ZI Medical Products, LLC's Kiva Vertebral Compression Fracture (VCF) Treatment System received CE Mark certification in Europe for the Kiva system. It is a VCF treatment method based on a unipedicular PEEK implant that has experienced clinical and commercial success in the United States.
Furthermore, in August 2020, IZI Medical Products launched its Osteo-Site Vertebral Balloon for vertebral augmentation. The Osteo-Site Balloon completes IZI's offering of Vertebral Compression Fracture ("VCF") treatment options, which include osteo-Site vertebroplasty, and osteo-site balloon kyphoplasty, blazer curved needle augmentation, and kiva PEEK Implant-based augmentation. Such initiatives of launching novel products in the market will further propel market growth.
Besides the above-mentioned factors, in individuals under the age of 55 who have had no or only minor trauma, metastatic cancers should be evaluated as a possible cause for vertebral compression fractures. Many forms of malignancies are known to spread via the spine's bones. During this, parts of the vertebra may be destroyed by cancer, weakening the bone until it Collapses. For instance, in December 2020, the International Agency for Research on Cancer (IARC) issued an updated Globocan 2020 report, revealing that the worldwide cancer burden has increased to 19.3 million cases and 10 million cancer deaths in 2020.
However, risks associated with post-surgical complications, including hemorrhage, vertebral posterior element fracture, and others, stringent regulatory approval for the devices, and reimbursement issues, among others, are expected to hamper the market growth.
Vertebral Compression Fracture Devices Market Trends
Minimally Invasive Spine Surgery Segment is Expected to Hold a Significant Share Over the Forecast period.
The minimally invasive spine surgery segment is expected to hold a significant market share, and it is expected to do the same over the forecast period.
With innovations in perfusion techniques, refinement of spinal fusion, and the development of specialized surgical instruments and robotic technology, vertebral compression fracture surgery was provided with the necessary tools to progress to less invasive approaches. The goal of the minimally invasive spine (MIS) surgery is to stabilize the vertebral bones and spinal joints and/or relieve the pressure being applied to the spinal nerves, often a result of conditions such as vertebral compression fractures, spinal instability, bone spurs, herniated discs, scoliosis, or spinal tumors.
The rise in initiatives by the market players in the vertebral compression fracture devices market is expected to drive this segment growth further. For instance, in February 2021, DePuy Synthes formed a deal with Expanding Innovations Inc. to market the X-Pac Expandable Lumbar Cage System in the United States. The X-Pac Cage adds to DePuy Synthes' existing product line, allowing for a more thorough procedure in the lumbar degenerative and minimally invasive spine segments.
In addition, in October 2021, Medtronic introduced three new devices to its minimally invasive spinal technologies ecosystem, making it the company to combine spinal implants, biologics, navigation, robotics, and AI-powered data for surgeons and patients. Such initiatives by the key players in spine surgical devices are therefore expected to drive the growth of this segment over the forecast period.
Therefore, owing to the aforementioned factors, this segment is expected to drive over the forecast period.
North America Holds a Major Share and Expected to do Same in the Forecast Period
North America holds a major share in the vertebral compression fracture devices market, and it is expected to do the same over the forecast period.
The factors owing to the growth of the market in this region include advancements in minimally invasive surgeries, the rise in prevalence of target diseases, the rise in research funding for trauma-related head and spine injuries, strong foothold of key market players, among others.
According to the report, 'A National Public Health Agenda for Osteoarthritis: 2020 Update' published by the Center for Disease Control and Prevention, Osteoarthritis (OA) is the most common form of arthritis, and it is a serious chronic disease that affects 1 in 7 United States adults making the count to 32.5 million people. Such a high incidence of osteoporosis is expected to drive the growth of the market studied in this region due to the higher adoption of vertebral compression fracture devices in fractures related to osteoporosis.
In addition, rising initiatives of key market players are also expected to propel the market growth in this region over the forecast period. For instance, in August 2021, Vertefix HV Cement, a unique solution that addresses the need for real-time flow visualization during cement injection for vertebroplasty and kyphoplasty procedures, was launched by IZI Medical Products LLC, a manufacturer of interventional radiology devices and products to treat vertebral compression fractures. Such initiatives will lead to increased adoption of vertebral compression fracture devices along with the adoption of cement, driving the market growth in the United States.
Furthermore, according to the America Health Rankings 2021 Senior Report, in the United States, there are more than 54 million individuals aged 65 and above. The number of older adults in the United States is huge and expanding, and by 2050, the total number of persons 65 and over in the United States is expected to reach 85.7 million, or nearly 20% of the total population. As vertebral compression fractures are more common as people become older, the rise in the elderly population will therefore be expected to propel the market growth in this region.
Therefore, owing to the above-mentioned factors, the market is expected to drive in this region over the forecast period.
Vertebral Compression Fracture Devices Market Competitor Analysis
The vertebral compression fracture devices market is moderately competitive. The market is expected to drive due to the rise in product launches by the key market players, the rise in partnerships, mergers, and acquisitions among the market players, among others. Some of the key players in the market include Spirit Spine Holding Corporation Inc, IZI Medical Products, Stryker Corporation (Orthovita, Inc.), Orthofix Interventional N.V., Johnson and Johnson (DePuy Synthes), Globus Medical, Inc., and Merit Medical Systems Inc., among others.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
- 4.1 Market Overview
- 4.2 Market Drivers
- 4.2.1 Growing Burden of Arthritis and Osteoporosis
- 4.2.2 Rising Burden of Compressed Bones of the Spine due to Trauma, Cancer, and Others
- 4.2.3 Increase in Awareness About Advancements in Spinal Surgeries
- 4.3 Market Restraints
- 4.3.1 Risks Associated with Post-Surgical Complications Including Hemorrhage, Vertebral Posterior Element Fracture and Others
- 4.3.2 Stringent Regulatory Approval Procedures and Reimbursement Issues
- 4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market size in USD million)
- 5.1 By Product Type
- 5.1.1 Balloon kyphoplasty
- 5.1.2 Vertebroplasty
- 5.2 By Surgery
- 5.2.1 Open spine surgery
- 5.2.2 Minimally Invasive Spine Surgery
- 5.3 By End User
- 5.3.1 Hospitals
- 5.3.2 Ambulatory Surgical Centers
- 5.3.3 Others (Trauma Centers and Others)
- 5.4 Geography
- 5.4.1 North America
- 5.4.1.1 United States
- 5.4.1.2 Canada
- 5.4.1.3 Mexico
- 5.4.2 Europe
- 5.4.2.1 Germany
- 5.4.2.2 United Kingdom
- 5.4.2.3 France
- 5.4.2.4 Italy
- 5.4.2.5 Spain
- 5.4.2.6 Rest of Europe
- 5.4.3 Asia-Pacific
- 5.4.3.1 China
- 5.4.3.2 Japan
- 5.4.3.3 India
- 5.4.3.4 Australia
- 5.4.3.5 South Korea
- 5.4.3.6 Rest of Asia-Pacific
- 5.4.4 Middle-East
- 5.4.4.1 GCC
- 5.4.4.2 South Africa
- 5.4.4.3 Rest of Middle-East
- 5.4.5 South America
- 5.4.5.1 Brazil
- 5.4.5.2 Argentina
- 5.4.5.3 Rest of South America
- 5.4.1 North America
6 COMPETITIVE LANDSCAPE
- 6.1 Company Profiles
- 6.1.1 Spirit Spine Holding Corporation Inc
- 6.1.2 Medtronic Inc.
- 6.1.3 IZI Medical Products
- 6.1.4 Stryker Corporation (Orthovita, Inc.)
- 6.1.5 Spine Wave, Inc.
- 6.1.6 Orthofix Interventional N.V.
- 6.1.7 Zimmer Biomet
- 6.1.8 Johnson and Johnson (DePuy Synthes)
- 6.1.9 Zavation
- 6.1.10 Globus Medical, Inc.
- 6.1.11 Merit Medical Systems Inc.
